Helicobacter pylori and complicated ulcer disease (Q34733169)

4 August 2017

1 reference

title

Helicobacter pylori and complicated ulcer disease. (English)

1 reference

Helicobacter pylori infectious disease

4 August 2017

0 references

1 reference

Laine LA

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

American Journal of Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

100

1 reference

4 August 2017

issue

5A

1 reference

4 August 2017

page(s)

52S-57S; discussion 57S-59S

1 reference

4 August 2017

cites work

Bleeding peptic ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Chemical gastritis induced by naproxen in the absence of Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double‐blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease. A prospective study in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Mucosal erosions in longterm non-steroidal anti-inflammatory drug users: predisposition to ulceration and relation to Helicobacter pylori.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

A randomized trial of nonoperative treatment for perforated peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Ranitidine and recurrent hemorrhage from duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Maintenance ranitidine treatment after haemorrhage from a duodenal ulcer. A 3-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Omeprazole, campylobacter pylori, and duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980229-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(96)80229-4

1 reference

4 August 2017

1 reference